Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
REPROS THERAPEUTICS (NQ: RPRX)
16.50 USD  +0.68 (+4.30%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about REPROS THERAPEUTICS
 
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
5 Pharmaceutical Stocks to Buy Now
May 24, 2013
 Read More
category NYSE:JNJ , NYSE:WPI , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
FDA Recommends Running Phase 2b Trial of Repros' Proellex-V
May 22, 2013
Repros Therapeutics (NASDAQ: RPRX ) today announced it has met with the FDA regarding the clinical development of Proellex-V, the vaginally administered product, in the treatment of uterine fibroids.... Read More
category RPRX , Contracts , Management , and 4 more.
from Latest Articles from Benzinga.com
FDA Recommends Running Phase 2b Trial of Proellex(R)-V in the Treatment of Severe Menstrual Bleeding Associated With Uterine Fibroids
May 22, 2013
from GlobeNewswire News Releases
Repros Therapeutics Crosses Above its 10-day MA (RPRX)
May 22, 2013
from Comtex SmarTrend® News Briefs
4 Pharmaceutical Stocks to Buy Now
May 17, 2013
 Read More
category NYSE:JNJ , NYSE:WPI , Stocks to Buy , and 2 more.
from InvestorPlace - Latest Headlines
Repros Therapeutics (RPRX) - Market Recap
May 17, 2013
NEW YORK (AVAFIN) -- Trading of Repros Therapeutics options resulted in establishing a new ... Read More
from AVAFIN
Repros Therapeutics (RPRX) moves higher despite loss
May 10, 2013
Repros Therapeutics Inc (NASDAQ: RPRX) shares gained 0.5% to $18.37, after announcing a quarterly net loss of $7.4 million, or $0.41 per share, as compared to a net loss of $2.4 million, or $0.17 per... Read More
from BAYSTREET RSS FEED
Repros Therapeutics, Inc. (RPRX) Posts Q1 Loss of 41c/Share
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8326165 for the full story. Read More
from StreetInsider.com News Articles
Repros Therapeutics Inc.(R) Reports First Quarter 2013 Financial Results
May 10, 2013
from GlobeNewswire News Releases
5 Pharmaceutical Stocks to Buy Now
May 10, 2013
 Read More
category NYSE:JNJ , NYSE:WPI , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
4 Pharmaceutical Stocks to Buy Now
May 03, 2013
 Read More
category NYSE:JNJ , NYSE:WPI , Stocks to Buy , and 2 more.
from InvestorPlace - Latest Headlines
Repros Therapeutics Up 25.8% Since SmarTrend Uptrend Call (RPRX)
May 03, 2013
from Comtex SmarTrend® News Briefs
Repros Reports Second Pivotal Androxal(R) Study Fully Enrolled Ahead of Schedule
May 02, 2013
from GlobeNewswire News Releases
Before the Bell Scans of PDLI, BCRX, ARRY, and RPRX
May 02, 2013
from ACCESSWIRE
Repros' Proellex(R) in Breast Cancer Phase 2 Study in Collaboration With Northwestern University
April 29, 2013
from GlobeNewswire News Releases
Repros to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
April 29, 2013
from GlobeNewswire News Releases
4 Pharmaceutical Stocks to Buy Now
April 26, 2013
 Read More
category NYSE:JNJ , NYSE:WPI , Stocks to Buy , and 2 more.
from InvestorPlace - Latest Headlines
Uptrend Call Working As Repros Therapeutics Stock Rises 30.4% (RPRX)
April 26, 2013
from Comtex SmarTrend® News Briefs
(RPRX) Repros Therapeutics Gets Additional Patents
April 21, 2013
Repros Therapeutics Inc. (RPRX) recently announced that two additional patents covering its... Visit StockBlogHub to view complete post. Read More
category Repros Therapeutics Inc , Transcept Pharmaceuticals Inc , Biotechnology , and 7 more.
from Stock Blog Hub
4 Pharmaceutical Stocks to Buy Now
April 19, 2013
 Read More
category NYSE:JNJ , NYSE:WPI , Stocks to Buy , and 2 more.
from InvestorPlace - Latest Headlines
Notable Gainers: McEwen Mining Inc, Repros Therapeutics Inc, Peabody Energy Corporation, BPZ Resources Inc
April 19, 2013
Lakeway, NY -- (SBWIRE) -- 04/19/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
MEI Pharma, Inc. (NASDAQ:MEIP), Repros Therapeutics Inc. (NASDAQ:RPRX), and Amicus Therapeutics, Inc. (NASDAQ:FOLD) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 18, 2013
New York, NY -- (SBWIRE) -- 04/18/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding MEI Pharma, Inc. (NASDAQ:MEIP), Repros Therapeutics Inc. (NASDAQ:RPRX), and Amicus... Read More
from SBWire - Latest Press Releases
Stocks to Watch for April 18, 2013
April 17, 2013
category RPRX , BCRX , INTC , and 3 more.
from AC Investor Blog
Stocks To Watch For April 18, 2013
April 17, 2013
( click to enlarge ) BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) rebounded from the support line located at $1.76 and closed the day near the highs, gaining 6.18% on the session. I’m watching the... Read More
category RIGL , intc , External Research , and 6 more.
from DailyMarkets.com
Wednesday Sector Leaders: Drugs, Cigarettes & Tobacco Stocks
April 17, 2013
In trading on Wednesday, drugs shares were relative leaders, down on the day by about 1%. Leading the group were shares of Acura Pharmaceuticals (ACUR), up about 50.2% and shares of Repros Therapeutics... Read More
category Stocks
from Market News Video
4 Pharmaceutical Stocks to Buy Now
April 12, 2013
 Read More
category NYSE:JNJ , NYSE:WPI , Stocks to Buy , and 2 more.
from InvestorPlace - Latest Headlines
Stock Winners: Sinclair Broadcast Group, Inc. (NASDAQ:SBGI), Baidu.com, Inc. (ADR) (NASDAQ:BIDU), Repros Therapeutics Inc (NASDAQ:RPRX)
April 11, 2013
Dallas, TX -- (SBWIRE) -- 04/11/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
News Briefing for Health Care Sector Companies: Embark Holdings, Vitamin Shoppe, MusclePharm, Repros Therapeutics, Unilife and Pfizer
April 11, 2013
from PR Newswire
Repros (RPRX) Receives Two More Patents Covering Androxal Indications
April 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8245142 for the full story. Read More
from StreetInsider.com News Articles
Repros Reports Issuance of Two Additional U.S. Androxal(R) Patents
April 10, 2013
from GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here